Company Filing History:
2 out of 2 
2 out of 2 
2 out of 2 Years Active: 2021-2025
Title: The Innovations of Daniel Richard Marshall
Introduction
Daniel Richard Marshall is a notable inventor based in New Haven, CT, with a significant contribution to the field of medical treatments. He holds a total of six patents, showcasing his dedication to advancing healthcare solutions. His work primarily focuses on innovative methods for treating diseases that involve acidic or hypoxic diseased tissues.
Latest Patents
Among his latest patents are groundbreaking inventions such as "Methods for treatment of diseases involving acidic or hypoxic diseased tissues" and "Peptide conjugates of cytotoxins as therapeutics." The first patent addresses compounds for treating diseases characterized by acidic or hypoxic conditions, along with pharmaceutical compositions that utilize these compounds. The second patent involves peptide conjugates of cytotoxins, specifically topoisomerase I inhibitors, which are aimed at treating diseases like cancer.
Career Highlights
Daniel has worked with companies such as Cybrexa 1, Inc. and Cybrexa 3, Inc., where he has applied his expertise in developing innovative therapeutic solutions. His career reflects a commitment to improving patient outcomes through scientific advancements.
Collaborations
Throughout his career, Daniel has collaborated with esteemed colleagues, including Robert A. Volkmann and Johanna Csengery. These partnerships have contributed to the success of his inventions and the development of new therapeutic strategies.
Conclusion
Daniel Richard Marshall's contributions to medical innovation are significant, particularly in the treatment of challenging diseases. His patents reflect a deep understanding of complex medical issues and a commitment to finding effective solutions.